stock.name

Theravance Biopharma Inc

TBPH

Market Cap$431.56M
Close$

Compare Theravance Biopharma

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Theravance Biopharma IncTheravance Biopharma Inc-7.80%-26%90.2
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$10.36

Current Fair Value

15% upside

Undervalued by 15% based on the discounted cash flow analysis.

Share Statistics

Market cap$431.56 Million
Enterprise Value$378.29 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.0
Beta0.47
Outstanding Shares48,164,708
Avg 30 Day Volume362,197

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-7.82
PEG43.75
Price to Sales9.01
Price to Book Ratio2.25
Enterprise Value to Revenue6.59
Enterprise Value to EBIT-7.1
Enterprise Value to Net Income-7
Total Debt to Enterprise0.13
Debt to Equity0.23

Revenue Sources

No data

ESG Score

No data

About Theravance Biopharma Inc

CEO: Rick Winningham